<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health and Prostate &#187; Book review</title>
	<atom:link href="http://healthandprostate.com/category/book-review/feed" rel="self" type="application/rss+xml" />
	<link>http://healthandprostate.com</link>
	<description>Benign Prostatic Hyperplasia - Prostate Cancer - Prostatitis</description>
	<lastBuildDate>Fri, 28 Oct 2011 14:09:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>What is the best medical treatment for BPH?</title>
		<link>http://healthandprostate.com/book-review/what-is-the-best-medical-treatment-for-bph</link>
		<comments>http://healthandprostate.com/book-review/what-is-the-best-medical-treatment-for-bph#comments</comments>
		<pubDate>Sun, 07 Mar 2010 08:04:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>
		<category><![CDATA[Finasteride]]></category>
		<category><![CDATA[Hytrin]]></category>
		<category><![CDATA[Proscar]]></category>
		<category><![CDATA[Terazosin]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=425</guid>
		<description><![CDATA[Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CU. The efficacy of terazosin, finasteride or both in benign prostate hyperplasia. N Engl J Med 1996; 335:533-9. Research question There are two main types of medications for the treatment of benign prostate hyperplasia (BPH): the first are α-adrenergic-antagonist drugs (eg, terazosin) that relax the smooth muscle in the prostate and the second are 5-α-reductase inhibitors (eg, finasteride) that block formation of dihydrotestosterone and thereby shrink the prostate. Which works better? Does a combination of the two drugs work best? Type of article and design Randomized, controlled trial of therapy. Relevance to family physicians In the last few years you could hardly open a medical journal without being bombarded with information about finasteride (Proscar). Many of us were using terazosin (Hytrin) also to treat BPH patients who had symptoms or were tired of "watchful waiting." Terazosin is cheaper, is covered on most provincial formularies, and works faster, but we often wondered which drug was more effective and whether a combination Read more [...]]]></description>
			<content:encoded><![CDATA[Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CU.
The efficacy of terazosin, finasteride or both in benign prostate hyperplasia.
 N Engl J Med 1996; 335:533-9.
Research question
There are two main types of medications for the treatment of benign prostate hyperplasia (BPH): the first are α-adrenergic-antagonist drugs (eg, terazosin) that relax the smooth muscle in the prostate and the second are 5-α-reductase inhibitors (eg, finasteride) that block formation of dihydrotestosterone and thereby shrink the prostate. Which works better? Does a combination of the two drugs work best?
Type of article and design
Randomized, controlled trial of therapy.
Relevance to family physicians
In the last few years you could hardly open a medical journal without being bombarded with information about finasteride (Proscar). Many of us were using terazosin (Hytrin) also to treat BPH patients who had symptoms or were tired of "watchful waiting." Terazosin is cheaper, is covered on most provincial formularies, and works faster, but we often wondered which drug was more effective and whether a combination <a href="http://healthandprostate.com/book-review/what-is-the-best-medical-treatment-for-bph" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/what-is-the-best-medical-treatment-for-bph/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Private Parts. An Owner&#8217;s Guide to the Male Anatomy</title>
		<link>http://healthandprostate.com/book-review/private-parts-an-owners-guide-to-the-male-anatomy</link>
		<comments>http://healthandprostate.com/book-review/private-parts-an-owners-guide-to-the-male-anatomy#comments</comments>
		<pubDate>Sun, 24 Jan 2010 03:33:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=377</guid>
		<description><![CDATA[Yosh Taguchi McClelland &#38; Stewart Inc, Suite 900, 481 University Ave, Toronto, ON M5G 2E9 1996/320 pp Strengths Easy to read, no-nonsense language, mostly accurate information Weaknesses Not always strongly evidence-based, sometimes too much emphasis on surgery, not patient-centred This is Dr Taguchi's second and updated edition of his "Canadian bestseller" first published in 1988. He is a well-known Montreal urologist who says he wrote this as "... the answer to all those questions I have ever been asked... in my office." Further, as it says on the jacket, "Most men know more about their cars than about the workings of their own bodies." Many family physicians would agree. This book is a cleanly laid out, how-to manual for men who want to know more about their genitourinary system. The first chapter deals with basic anatomy and functions. The rest covers various problem areas, such as impotence (when will the medical establishment call this erectile dysfunction?), infertility, vasectomy, lumps, prostate problems, sexually transmitted diseases, and incontinence. The information Read more [...]]]></description>
			<content:encoded><![CDATA[




Yosh Taguchi
McClelland &amp; Stewart Inc, Suite 900, 481 University Ave, Toronto, ON M5G 2E9
1996/320 pp
Strengths
Easy to read, no-nonsense language, mostly accurate information
Weaknesses
Not always strongly evidence-based, sometimes too much emphasis on surgery, not patient-centred

This is Dr Taguchi's second and updated edition of his "Canadian bestseller" first published in 1988. He is a well-known Montreal urologist who says he wrote this as "... the answer to all those questions I have ever been asked... in my office." Further, as it says on the jacket, "Most men know more about their cars than about the workings of their own bodies." Many family physicians would agree.

This book is a cleanly laid out, how-to manual for men who want to know more about their genitourinary system. The first chapter deals with basic anatomy and functions. The rest covers various problem areas, such as impotence (when will the medical establishment call this erectile dysfunction?), infertility, vasectomy, lumps, prostate problems, sexually transmitted diseases, and incontinence. The information <a href="http://healthandprostate.com/book-review/private-parts-an-owners-guide-to-the-male-anatomy" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/private-parts-an-owners-guide-to-the-male-anatomy/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Review: Benign Prostatic Hypertrophy</title>
		<link>http://healthandprostate.com/book-review/review-benign-prostatic-hypertrophy</link>
		<comments>http://healthandprostate.com/book-review/review-benign-prostatic-hypertrophy#comments</comments>
		<pubDate>Wed, 30 Dec 2009 23:22:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>
		<category><![CDATA[Finasteride]]></category>
		<category><![CDATA[Terazosin]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=294</guid>
		<description><![CDATA[Finasteride reduced symptoms and need for surgery for benign prostatic hypertrophy. Commentator, Barry, M. Massachusetts General Hospital, Boston, MA, USA. Evidence-based Medicine, 3(4): 107, July/Aug. 1998. The following article is briefly presented The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. McConnel, J., Bruskewitz, R., Walsh, P. et al. N Engl J Med, 338: 557-563, 26 Feb. 1998. This was a 4-year randomized double-blind placebo-controlled trial involving around 3000 men who had BPH with moderate to severe lower urinary tract symptoms, decreased maximal urine flow rates and an enlarged prostate. They were randomized to receive either finasteride at 5 mg/day or placebo for 4 years. The authors found the following: • Those who had received finasteride had significantly greater decreases in symptom scores. Significantly fewer men in the finasteride group had surgery or acute urine retention. •There was a significantly higher incidence of side effects in the finasteride group. Commentary The Read more [...]]]></description>
			<content:encoded><![CDATA[Finasteride reduced symptoms and need for surgery for benign prostatic hypertrophy. Commentator, Barry, M. Massachusetts General Hospital, Boston, MA, USA.
Evidence-based Medicine, 3(4): 107, July/Aug. 1998.

The following article is briefly presented

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. McConnel, J., Bruskewitz, R., Walsh, P. et al.
N Engl J Med, 338: 557-563, 26 Feb. 1998.

This was a 4-year randomized double-blind placebo-controlled trial involving around 3000 men who had BPH with moderate to severe lower urinary tract symptoms, decreased maximal urine flow rates and an enlarged prostate. They were randomized to receive either finasteride at 5 mg/day or placebo for 4 years.

The authors found the following:

• Those who had received finasteride had significantly greater decreases in symptom scores. Significantly fewer men in the finasteride group had surgery or acute urine retention.

•There was a significantly higher incidence of side effects in the finasteride group.

Commentary

The <a href="http://healthandprostate.com/book-review/review-benign-prostatic-hypertrophy" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/review-benign-prostatic-hypertrophy/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prostate Cancer</title>
		<link>http://healthandprostate.com/book-review/prostate-cancer</link>
		<comments>http://healthandprostate.com/book-review/prostate-cancer#comments</comments>
		<pubDate>Wed, 30 Dec 2009 21:22:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=292</guid>
		<description><![CDATA[Editorial - Controversy in managing patients with prostate cancer. Mulley, A. and Barry, M. General Medical Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. BMJ, 316(7149): 19219-19220, 27 June 1998. and Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom. Donovan, J., Frankel, S., Faulkner, A., Selley, S., Gillat, E. and Hamdy, F. Department of Social Medicine, University of Bristol, Bristol, UK. BNU, 318(7179): 299-300, 30 Jan. 1999. The effectiveness of radical treatments (prostatectomy and radiotherapy) for prostate cancer over conservative management (surveillance plus hormonal therapy if required) is debatable. Also, quality of life after radical treatment may be poor compared with conservative management. Because of this lack of evidence, controversy still remains over the best form of treatment. Two surveys of British urologists (Savage asked 274 urologists, Br J Urol, 1997; Donovan asked 244 urologists, BMJ, Jan. 1999), found that most favoured active treatment Read more [...]]]></description>
			<content:encoded><![CDATA[Editorial - Controversy in managing patients with prostate cancer. Mulley, A. and Barry, M. General Medical Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
BMJ, 316(7149): 19219-19220, 27 June 1998.

and

Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom. Donovan, J., Frankel, S., Faulkner, A., Selley, S., Gillat, E. and Hamdy, F. Department of Social Medicine, University of Bristol, Bristol, UK.
BNU, 318(7179): 299-300, 30 Jan. 1999.

The effectiveness of radical treatments (prostatectomy and radiotherapy) for prostate cancer over conservative management (surveillance plus hormonal therapy if required) is debatable. Also, quality of life after radical treatment may be poor compared with conservative management. Because of this lack of evidence, controversy still remains over the best form of treatment. Two surveys of British urologists (Savage asked 274 urologists, Br J Urol, 1997; Donovan asked 244 urologists, BMJ, Jan. 1999), found that most favoured active treatment <a href="http://healthandprostate.com/book-review/prostate-cancer" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/prostate-cancer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Collection of papers on urinary incontinence</title>
		<link>http://healthandprostate.com/book-review/collection-of-papers-on-urinary-incontinence</link>
		<comments>http://healthandprostate.com/book-review/collection-of-papers-on-urinary-incontinence#comments</comments>
		<pubDate>Sun, 27 Dec 2009 23:15:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=297</guid>
		<description><![CDATA[Urinary Incontinence in the Elderly. Pharmacotherapy Treatment Editor: James W. Cooper The Haworth Press, Inc, 10 Alice St, Binghamton, NY 13904-1580 USA 1997, 72 pp Overall Rating Good Strengths Comprehensive, current, useful information Weakness Information is difficult to access, is in table format, and is in small print Audience Family physicians, other health care providers, and caregivers Urinary Incontinence in the Elderly is not so much a textbook as it is a collection of papers dealing with different aspects of urinary incontinence (UI). As such, the articles might be useful to different audiences. For physicians whose practices primarily involve the elderly, either in the office or in long-term care settings, this book has many excellent features. There is a comprehensive overview of the risk factors, clinical evaluation, and treatment of urinary incontinence. This information is presented primarily in table format. Although the title suggests only pharmacologie treatment, other management options, such as behavioural interventions and surgical treatments, Read more [...]]]></description>
			<content:encoded><![CDATA[ 



Urinary Incontinence in the Elderly. Pharmacotherapy Treatment

Editor: James W. Cooper

The Haworth Press, Inc, 10 Alice St, Binghamton, NY 13904-1580 USA

1997, 72 pp
Overall Rating
Good
Strengths
Comprehensive, current, useful information
Weakness
Information is difficult to access, is in table format, and is in small print
Audience
Family physicians, other health care providers, and caregivers

Urinary Incontinence in the Elderly is not so much a textbook as it is a collection of papers dealing with different aspects of urinary incontinence (UI). As such, the articles might be useful to different audiences.

For physicians whose practices primarily involve the elderly, either in the office or in long-term care settings, this book has many excellent features. There is a comprehensive overview of the risk factors, clinical evaluation, and treatment of urinary incontinence. This information is presented primarily in table format. Although the title suggests only pharmacologie treatment, other management options, such as behavioural interventions and surgical treatments, <a href="http://healthandprostate.com/book-review/collection-of-papers-on-urinary-incontinence" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/collection-of-papers-on-urinary-incontinence/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer therapy for some</title>
		<link>http://healthandprostate.com/book-review/cancer-therapy-for-some</link>
		<comments>http://healthandprostate.com/book-review/cancer-therapy-for-some#comments</comments>
		<pubDate>Tue, 22 Dec 2009 00:01:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=302</guid>
		<description><![CDATA[, 2nd Ed Authors: Malin Dollinger, Ernest H. Rosenbaum, Greg Cable Editor: Richard Hasselback Somerville House Books limited, 3080 Yonge St, Suite 5000, Toronto, ON M4N 3N1 1995, 706 pp Overall Rating Good Strengths A good overview of cancer care for health professionals from a psychosocial, technical, and medical perspective. Forty-seven common cancers are concisely described in the last part of the book Weaknesses Content varies greatly in technical complexity, making it difficult reading for general readers. The book implies that it is accessible to everyone but remains a resource for health professionals Audience Health professionals, including family physicians, nurses, interns, residents, and medical students. Those very knowledgeable in health science could be a secondary audience I anticipated the opportunity to read this book because of my clinical care of people living with cancer, and more recently, my contact with family members living with cancer. The book is divided into five parts: diagnosis and treatment; supportive care; quality of life; new advances Read more [...]]]></description>
			<content:encoded><![CDATA[



, 2nd Ed

Authors: Malin Dollinger, Ernest H. Rosenbaum, Greg Cable

Editor: Richard Hasselback

Somerville House Books limited, 3080 Yonge St, Suite 5000, Toronto, ON M4N 3N1

1995, 706 pp
Overall Rating
Good
Strengths
A good overview of cancer care for health professionals from a psychosocial, technical, and medical perspective. Forty-seven common cancers are concisely described in the last part of the book
Weaknesses
Content varies greatly in technical complexity, making it difficult reading for general readers. The book implies that it is accessible to everyone but remains a resource for health professionals
Audience
Health professionals, including family physicians, nurses, interns, residents, and medical students. Those very knowledgeable in health science could be a secondary audience

I anticipated the opportunity to read this book because of my clinical care of people living with cancer, and more recently, my contact with family members living with cancer.

The book is divided into five parts: diagnosis and treatment; supportive care; quality of life; new advances <a href="http://healthandprostate.com/book-review/cancer-therapy-for-some" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/cancer-therapy-for-some/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Prostate Problem. Benign Prostatic Hyperplasia: A Physician&#8217;s Guide To Care And Counselling</title>
		<link>http://healthandprostate.com/book-review/a-prostate-problem-benign-prostatic-hyperplasia-a-physicians-guide-to-care-and-counselling</link>
		<comments>http://healthandprostate.com/book-review/a-prostate-problem-benign-prostatic-hyperplasia-a-physicians-guide-to-care-and-counselling#comments</comments>
		<pubDate>Sat, 28 Nov 2009 13:50:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Book review]]></category>
		<category><![CDATA[Finasteride]]></category>
		<category><![CDATA[Terazosin]]></category>

		<guid isPermaLink="false">http://healthandprostate.com/?p=73</guid>
		<description><![CDATA[J. Curtis Nickel; Richard W. Norman Grosvenor House Press Inc, King West Centre, 2 PardeeAve, Suite 203, Toronto, 0NM6K3H5. Available through the Canadian Medical Association, PO Box 8650, 1867 Alta Vista, Ottawa, ON K1G 0G8, 1993, 88 pp This attractive softcover manual is part of the Canadian Medical Association's Disease Management / Patient Counselling series. Written by two urologists, the chapters, though short, cover essential material in enough depth that readers do not feel shortchanged or patronized. References are sufficient and up-to-date, and the text is well written, well organized, well presented, and well illustrated. Topics covered include the definition, pathology, pathophysiology, and natural history of benign prostatic hyperplasia. Symptoms and signs are lucidly explained. Investigative procedures that are sometimes necessary are explained, but needless investigations are discouraged. A variety of therapeutic options are described, including "watchful waiting"; medical therapy with α-adrenergic blockers, such as terazosin; 5-alpha reductase inhibitors, such as finasteride; Read more [...]]]></description>
			<content:encoded><![CDATA[J. Curtis Nickel; Richard W. Norman
Grosvenor House Press Inc, King West Centre, 2 PardeeAve, Suite 203, Toronto, 0NM6K3H5. Available through the Canadian Medical Association, PO Box 8650, 1867 Alta Vista, Ottawa, ON K1G 0G8, 1993, 88 pp

This attractive softcover manual is part of the Canadian Medical Association's Disease Management / Patient Counselling series. Written by two urologists, the chapters, though short, cover essential material in enough depth that readers do not feel shortchanged or patronized. References are sufficient and up-to-date, and the text is well written, well organized, well presented, and well illustrated.

Topics covered include the definition, pathology, pathophysiology, and natural history of benign prostatic hyperplasia. Symptoms and signs are lucidly explained. Investigative procedures that are sometimes necessary are explained, but needless investigations are discouraged. A variety of therapeutic options are described, including "watchful waiting"; medical therapy with α-adrenergic blockers, such as terazosin; 5-alpha reductase inhibitors, such as finasteride; <a href="http://healthandprostate.com/book-review/a-prostate-problem-benign-prostatic-hyperplasia-a-physicians-guide-to-care-and-counselling" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://healthandprostate.com/book-review/a-prostate-problem-benign-prostatic-hyperplasia-a-physicians-guide-to-care-and-counselling/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

